The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Adverum Biotechnologies, Inc(NASDAQ:ADVM) 
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal dis...
Website: http://www.adverum.com
Founded: 2006
Full Time Employees: 114
Sector: Healthcare
Industry: Biotechnology
Adverum Biotechnologies Days Payable Outstanding ttm (DPO)
Adverum Biotechnologies Days Receivable Outstanding ttm (DSO)
Adverum Biotechnologies Op Cashflow Per Share ttm
Adverum Biotechnologies Free Cashflow Per Share ttm
Adverum Biotechnologies Cash Per Share ttm
Adverum Biotechnologies P/S ratio ttm
Adverum Biotechnologies (GAAP) P/E ratio ttm
Adverum Biotechnologies P/B ratio ttm
No extra charts and metrics for this ticker.